Suppr超能文献

相似文献

1
miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
Biochem Biophys Res Commun. 2015 Sep 4;464(4):1309-1313. doi: 10.1016/j.bbrc.2015.07.128. Epub 2015 Jul 29.
2
MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
Biomed Pharmacother. 2017 Apr;88:443-448. doi: 10.1016/j.biopha.2016.11.090. Epub 2017 Jan 22.
4
miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
Biochem Biophys Res Commun. 2016 Jan 29;470(1):187-191. doi: 10.1016/j.bbrc.2016.01.025. Epub 2016 Jan 7.
5
miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA.
Biochem Biophys Res Commun. 2016 Sep 9;478(1):274-278. doi: 10.1016/j.bbrc.2016.07.031. Epub 2016 Jul 21.
6
MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
BMC Cancer. 2019 Nov 12;19(1):1093. doi: 10.1186/s12885-019-6319-4.
7
miR-664 negatively regulates PLP2 and promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia.
Biochem Biophys Res Commun. 2015 Apr 3;459(2):340-345. doi: 10.1016/j.bbrc.2015.02.116. Epub 2015 Feb 28.
8
LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma.
Horm Metab Res. 2024 May;56(5):392-399. doi: 10.1055/a-2196-3511. Epub 2023 Dec 5.
10
miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5.
Biochem Biophys Res Commun. 2015 Mar 13;458(3):714-719. doi: 10.1016/j.bbrc.2015.02.033. Epub 2015 Feb 14.

引用本文的文献

2
miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma.
Exp Ther Med. 2020 May;19(5):3203-3210. doi: 10.3892/etm.2020.8574. Epub 2020 Mar 6.
3
miR-544 inhibits the migration and invasion of anaplastic thyroid cancer by targeting Yin Yang-1.
Oncol Lett. 2019 Mar;17(3):2983-2992. doi: 10.3892/ol.2019.9915. Epub 2019 Jan 9.
6
Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
Cell Prolif. 2018 Jun;51(3):e12438. doi: 10.1111/cpr.12438. Epub 2018 Feb 19.
7
miRNA dysregulation and the risk of metastasis and invasion in papillary thyroid cancer: a systematic review and meta-analysis.
Oncotarget. 2017 Mar 29;9(4):5473-5479. doi: 10.18632/oncotarget.16681. eCollection 2018 Jan 12.
8
Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires.
Sci Adv. 2017 Dec 15;3(12):e1701133. doi: 10.1126/sciadv.1701133. eCollection 2017 Dec.
9
miR-130a Deregulates PTEN and Stimulates Tumor Growth.
Cancer Res. 2017 Nov 15;77(22):6168-6178. doi: 10.1158/0008-5472.CAN-17-0530. Epub 2017 Sep 21.
10
The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.
J Endocrinol Invest. 2018 Mar;41(3):269-283. doi: 10.1007/s40618-017-0735-6. Epub 2017 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验